If you would like to ask our webinar guest speakers from WS Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund a question please submit them here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSUBX.L Regulatory News (SUBX)

  • There is currently no data for SUBX

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

3rd Quarter Results

11 Feb 2016 12:18

RNS Number : 8092O
Subex Limited
11 February 2016
 

 

 

 

 

 

February 11, 2016

To

The London Stock Exchange

10 Paternoster Square

London

EC4M 7LS

Dear Sirs,

Sub: Subex Limited 'The Company'-Outcome of the Board Meeting held on February 10, 2016

Please be informed that the agenda item summarized hereunder was discussed and approved at the Board Meeting held on February 10, 2016

Ø Approval of the unaudited standalone and consolidated Financial Results of the Company for the quarter and nine months ended December 31, 2015.

 

 Please find hereto enclosed consolidated Financial Results of the Company.  

We request you to take the aforesaid notification on record.

Yours faithfully

For and on behalf of Subex Limited

 

Ganesh K V

Chief Financial Officer, Global Head -Legal and Company Secretary

 

 

SUBEX LIMITED

Registered office: RMZ Ecoworld, Outer Ring Road, Devarabisanahalli, Bangalore - 560 037

Statement of Consolidated Unaudited Results for the quarter and nine months ended December 31, 2015

PART I ( Rs. in Lakhs unless otherwise stated)

 

 

 

Particulars

Consolidated

 

3 months ended

December 31,

 

Preceding 3 months ended September 30,

Corresponding 3 months ended December 31,

 

Year to date figures for the nine months ended December 31,

 

Previous year ended

March 31,

2015

2015

2014

2015

2014

2015

Unaudited

Unaudited

Unaudited

Unaudited

Unaudited

Audited

1

 

 

 

 

 

2 (a) (b) (c) (d) (e)

 

 

3

 

 

4

5

 

 

6 (a) (b) (c)

 

 

7

 

 

8

9

 

10

 

 

11

 

12 (a)

(b)

Income from operations

Net sales/ income from operations

 

8,083

 

7,954

 

9,199

 

23,388

 

24,767

 

35,983

Total income from operations (net)

8,083

7,954

9,199

23,388

24,767

35,983

 

Expenses

Cost of hardware, software and support charges

Employee benefits expense and sub- contract charges (refer note 6) Other expenditure (refer note 7)

Depreciation and amortisation expense

Exchange fluctuation (gain)/loss (net) (refer note 3 (d)(ii))

 

 

 

84

4,127

2,115

110 (891)

 

 

77

4,287

1,883

105 (228)

 

 

107

4,452

2,111

86

48

 

 

180

12,948

5,758

317

57

 

 

509

12,937

6,033

309

438

 

 

1,664

16,376

8,685

402

1,250

Total expenses

5,545

6,124

6,804

19,260

20,226

28,377

Profit from operations before other income, finance costs and tax

(1-2)

2,538

1,830

2,395

4,128

4,541

7,606

 

Other income

 

14

 

11

 

25

 

58

 

37

 

97

Profit from ordinary activities before finance costs and tax (3+4)

2,552

1,841

2,420

4,186

4,578

7,703

 

Finance costs

Interest on FCCBs (net) (refer note 3(d)(i) & 3(e)) Interest on term loan

Other finance costs

 

 

(4,260)

245

375

 

 

(924)

244

324

 

 

818

220

478

 

 

(5,659)

720

1,011

 

 

2,513

631

1,467

 

 

3,352

850

1,902

Total finance costs

(3,640)

(356)

1,516

(3,928)

4,611

6,104

Profit/(Loss) from ordinary activities after finance costs before

tax (5-6)

6,192

2,197

904

8,114

(33)

1,599

 

Tax expense (net)

 

254

 

637

 

230

 

1,091

 

391

 

578

Net Profit/(Loss) for the period/year (7-8)

5,938

1,560

674

7,023

(424)

1,021

 

Paid up share capital

- Equity (face value of  Rs. 10/-)

 

Reserves excluding revaluation reserves as per balance sheet of previous accounting year

 

Earnings/(Loss) per share (of  Rs. 10/- each) (not annualised in case of the interim periods):

- Basic

- Diluted

 

 

42,175

 

 

-

 

 

 

1.82

1.31

 

 

26,402

 

 

-

 

 

 

0.73

0.59

 

 

17,476

 

 

-

 

 

 

0.40

0.40

 

 

42,175

 

 

-

 

 

 

2.86

2.06

 

 

17,476

 

 

-

 

 

 

(0.25) (0.25)

 

 

18,292

 

 

2,612

 

 

 

0.59

0.59

 

 

 

 

1

 

2

 

 

 

 

 

 

 

 

 

 

 

3

Notes :

The above results have been reviewed by the Audit Committee and approved by the Board of Directors in their meeting held on February 10, 2016.

 

The Financial Results of Subex Limited (Standalone Information): ( Rs. inLakhs)

 

 

Particulars

 

3 months ended

December 31,

 

Preceding 3 months ended September 30,

Corresponding 3

months ended

December 31,

 

Year to date figures for the nine months ended December 31,

 

Previous year ended

March 31,

2015

2015

2014

2015

2014

2015

Unaudited

Unaudited

Unaudited

Unaudited

Unaudited

Audited

Net sales/ income from operations

7,634

7,274

7,845

21,338

21,041

30,567

Profit/(Loss) from ordinary activities before tax

6,121

1,596

(445)

8,164

(2,956)

(2,685)

Profit/(Loss) from ordinary activities after tax

5,952

1,298

(512)

7,647

(3,061)

(2,840)

 

(a) Pursuant to the approval of the holders of "US$ 180 Million 2% convertible unsecured bonds", [of which US$ 39 Million was outstanding ("FCCBs I")] and "US$ 98.7 Million 5% convertible unsecured bonds", [of which US$ 54.8 Million was outstanding ("FCCBs II")], at their respective meetings held on July 05, 2012 and exchange offers received under the exchange offer memorandum dated June 13, 2012, holders of US$ 38 Million out of FCCBs I and US$ 53.4 Million out of FCCBs II offered their bonds for exchange. Consequently, secured bonds with a face value of US$ 127.721 Million ("FCCBs III") were issued with maturity date of July 07, 2017, having an interest rate of 5.70% p.a. payable semi-annually, an exchange rate for conversion of Rs.56.0545/US$ and an equity conversion price of Rs.22.79 per equity share. In accordance with the terms of FCCBs III, principal amount of US$ 36.321 Million was mandatorily converted into equity shares at the aforesaid conversion price on July 07, 2012. Further, pursuant to the approval of the Reserve Bank of India dated April 27, 2012 and requisite approvals of the bond holders, the maturity period of the un-exchanged portion of FCCBs I of US$ 1 Million and FCCBs II of US$ 1.4 Million stands extended to March 09, 2017, with its other terms and conditions remaining unchanged.

 

(b) The Board in its meeting held on May 14, 2015 has approved the reset of conversion price of the FCCBs III, which are convertible into equity shares of the Company, from Rs.22.79 to Rs.13.00 per equity share. Subsequently, the reset of the conversion price has been approved by the shareholders in the annual general meeting held on June 19, 2015 and the bondholders in their meeting held on August 5, 2015. The Board in its meeting held on August 26, 2015 has approved August 26, 2015 as the effective date of reset of conversion price of Rs.13 per share.

As a result of the aforesaid reset of conversion price, the said bonds with outstanding face value of US$ 23.35 Million as at December 31, 2015 would potentially be converted into 100,682,506 equity shares at an exchange rate of Rs.56.0545/US$ with a conversion price of Rs.13 per equity share. During the month of December 2015 and January 2016, conversion requests from the bondholders of FCCBs III amounting to US$ 9 million and US$ 7.8 Million respectively have been received by the Company, which are pending to be approved by the Board of Directors, which would potentially be converted into 72,439,662 equity shares at an exchange rate of Rs.56.0545/US$ with a conversion price of Rs.13 per equity share.

 

(c) (i) Of the outstanding FCCBs III of US$ 91.40 Million as of July 2012, US$ 68.05 Million have been converted till the quarter and nine months ended December 31, 2015.

 

Financial year/ period

 

FCCBs converted

US$ Million

 

Conversion rate per

US$

 

Conversion price

 

No. of equity shares

2012-13

3.25

Rs. 56.0545

Rs. 22.79

7,993,931

2014-15

6.62

Rs. 56.0545

Rs. 22.79

16,282,613

Quarter ended June 30, 2015

6.50

Rs. 56.0545

Rs. 22.79

15,987,461

Quarter ended September 30, 2015

15.10

Rs. 56.0545

Rs. 22.79

65,109,454

Quarter ended December 31, 2015

36.58

Rs. 56.0545

Rs. 22.79

157,728,731

 

(ii) The face value of FCCBs outstanding as on December 31, 2015 is as follows:

Particulars

US$ Million

Rs. in Lakhs

FCCBs I

1.00

662

FCCBs II

1.40

926

FCCBs III

23.35

15,447

Total

25.75

17,035

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

4

 

 

 

 

 

5

 

6

 

 

 

 

7

(d) (i) Interest on FCCBs is net of reversal of interest accrued but not due in relation to FCCBs III which has been written back as the same is considered no longer payable due to the conversion of FCCBs III into

equity shares of the Company. Such reversals for the quarter and comparative periods are as detailed below:

 

Particulars

 

3 months ended

December 31,

 

Preceding 3 months ended September 30,

Corresponding 3

months ended

December 31,

 

Year to date figures for the nine months ended December 31,

 

Previous year ended

March 31,

2015

2015

2014

2015

2014

2015

Unaudited

Unaudited

Unaudited

Unaudited

Unaudited

Audited

FCCBs converted (US$ million)

36.58

15.10

2.30

58.18

3.30

6.62

Reversal of interest accrued but not due (Rs.in lakhs)

(4,744)

(1,715)

-

(7,642)

-

-

(ii) Exchange fluctuation gain/loss is net of foreign exchange gain on conversion of FCCBs III at an exchange rate of Rs.56.0545/US$ as against the closing rate on the date of conversion ( in the range of Rs. 60 -  Rs.66), and amortisation of Foreign Currency Monetary Item Translation Difference Account ( 'FCMITD') arising out of conversion of FCCBs III into equity shares of the Company. Such net impact for the quarter and comparative periods are as detailed below:

 

Particulars

 

3 months ended

December 31,

 

Preceding 3 months ended September 30,

Corresponding 3

months ended

December 31,

 

Year to date figures for the nine months ended December 31,

 

Previous year ended

March 31,

2015

2015

2014

2015

2014

2015

Unaudited

Unaudited

Unaudited

Unaudited

Unaudited

Audited

FCCBs converted (US$ million)

36.58

15.10

2.30

58.18

3.30

6.62

Foreign exchange (gain)/ loss on conversion (net) (Rs.in lakhs)

(876)

(235)

32

(1,400)

58

40

(e) The FCCB bond holders in their respective meetings have approved the deferral of aggregate interest of US$ 4.71 Million ( Rs. 3,115.96 Lakhs) in respect of outstanding FCCBs III of USD 23.35 Million for the period July 6, 2012 to January 5, 2016 till redemption date of the bonds, being July 07, 2017. Accordingly, interest on FCCBs III included under finance costs in the above results is due for payment on July 07, 2017.

 

During the financial year ended March 31, 2015, the Company had assessed the carrying value of goodwill arising from its investment in its subsidiary viz. Subex Americas Inc., amounting to Rs. 18,606 Lakhs. Based on the management's assessment, there was no impairment of such goodwill taking into account the future operational plans and projected cash flows as prepared by the management and accordingly, no impairment loss was required to be recognised. The management continues to believe that, based on its assessment, there is no impairment of such goodwill as at December 31, 2015. This is an 'Emphasis of Matter' in the Limited Review Report of the Statutory Auditors on the Unaudited Consolidated Results.

 

The Company has only single business segment with respect to software products and related services and hence has not made any additional segment disclosures.

 

Employee benefits expense and sub-contract charges for the quarters ended December 31, 2015, September 30, 2015 and December 31, 2014 are net of reversal of provision no longer required, in respect of employee incentives, amounting to Rs. 420 Lakhs, Rs. 384 Lakhs, and Rs. Nil, respectively and that for the nine months ended December 31, 2015, December 31, 2014 and the year ended March 31, 2015 amounting to Rs. 873 Lakhs,

Rs. 287 Lakhs and Rs. 1,191 Lakhs, respectively.

 

Other expenditure for the quarter ended December 31, 2015, September 30, 2015 and December 31, 2014 is net of reversal of provision no longer required, in respect of commission on sales, amounting to Rs. 146

Lakhs, Rs. Nil and Rs. Nil, respectively and that for the nine months ended December 31, 2015, December 31, 2014 and the year ended March 31, 2015 amounting to Rs. 146 Lakhs, Rs. Nil and Rs. Nil, respectively.

 

 

 

8

 

 

 

 

 

 

 

 

 

 

 

 

9

 

 

10

Pursuant to the approval of the Board of Directors, the Company has discontinued the operations of two of its subsidiaries with effect from April 01, 2013. The details of unaudited/audited results of the discontinued business consolidated in the above results are as follows:

 

 

Particulars

 

3 months ended

December 31,

 

Preceding 3 months ended September 30,

Corresponding 3

months ended

December 31,

 

Year to date figures for the nine months ended December 31,

 

Previous year ended

March 31,

2015

2015

2014

2015

2014

2015

Unaudited

Unaudited

Unaudited

Unaudited

Unaudited

Audited

Total income

-

-

-

-

-

-

(Loss) /Profit before tax

(0.91)

(1.31)

0.34

(3.12)

(80.98)

(474.18)

(Loss) /Profit after tax

(0.93)

1.62

0.33

(0.22)

(81.26)

(479.80)

 

The figures of the previous period up to March 31, 2015 were audited/ reviewed by a firm of Chartered Accountants other than S.R. Batliboi & Associates LLP. Previous period/year figures have been regrouped/

reclassified, wherever necessary to confirm to current period's classification.

 

Pursuant to Regulation 33 of the SEBI (Listing Obligation and Disclosure Requirements) Regulations, 2015, the Company has opted to publish the consolidated financial results. The standalone financial results, however, are being made available to the Stock Exchanges where the securities of the Company are listed and are also being posted on the Company's website www.subex.com.

By Order of the Board

 

 

 

 

Mumbai Surjeet Singh

Date: February 10, 2016 Managing Director & CEO

 

For further details on the results, please visit our website: www.subex.com

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
QRTAKDDDBBKDKBD
Date   Source Headline
9th Aug 202210:35 amRNSOutcome of the Board Meeting held on August 8,2022
30th Jun 20223:42 pmRNSProposed termination of GDRs & De-listing
1st Jun 202211:52 amRNSOutcome of Board Meeting dated May 30, 2022
1st Feb 202211:11 amRNSOutcome of Board Meeting held on Jan 31, 2022
29th Oct 20218:37 amRNSOutcome of Board Meeting held on October 28, 2021
10th Aug 202111:41 amRNSOutcome of the Board Meeting on August 09, 2021
15th Jun 202111:56 amRNSNotice of Twenty Seventh Annual General Meeting
18th May 202111:20 amRNSOutcome of the Board Meeting held on May 17, 2021
2nd Feb 202112:38 pmRNSOutcome of the Board Meeting February 01,2021
10th Nov 202011:32 amRNSOutcome of the Board Meeting November 09,2020
1st Sep 202012:01 pmRNSNotice of the Twenty Sixth Annual General Meeting
11th Aug 20202:34 pmRNSOutcome of Board Meeting on August 10, 2020
12th May 20207:31 amRNSSubex Limited-Outcome of Board Meeting 11 May 2020
12th Feb 20207:00 amRNSOutcome of the Board Meeting of Subex Limited
11th Nov 201910:17 amRNSResults for quarter & half year ended Sep 30, 2019
13th Aug 201911:02 amRNSOutcome of the Board Meeting - August 12, 2019
10th Jun 201911:55 amRNSNotice of the Twenty Fifth Annual General Meeting
14th May 20199:51 amRNSSubex Limited Outcome -Board Meeting -May 13, 2019
30th Jan 20197:00 amRNSOutcome of the Board Meeting held on Jan 29, 2019
2nd Nov 20187:08 amRNSOutcome of the Board Meeting- October 31, 2018
1st Aug 20187:00 amRNS1st Quarter Results
12th Jul 20187:26 amRNSThe Twenty Fourth AGM of Subex Limited
27th Jun 20187:38 amRNSSubex Limited-Outcome -Board Meeting June 26,2018
4th May 20183:00 pmRNSFinal Results
22nd Mar 201811:29 amRNSAppointment of MD & CEO of Subex Ltd
30th Jan 20189:50 amRNSFinancial Results - 3rd Quarter
13th Nov 201710:01 amRNSOutcome of Board Meeting held on November 10 2017
2nd Nov 201711:54 amRNSRestructuring of the Business wef Nov 1, 2017
5th Oct 20177:00 amRNSOutcome of Board Meeting held on October 4, 2017
22nd Aug 201711:47 amRNSOutcome of Board Meeting held on August 21, 2017
31st Jul 201711:38 amRNS1st Quarter Results
10th Jul 201711:40 amRNSRedemption of FCCB III
4th Jul 201711:05 amRNSNotice of AGM
5th Jun 201711:25 amRNSOutcome of the Board Meeting held on June 05, 2017
5th Jun 201711:15 amRNSOutcome of the Board Meeting held on June 05, 2017
26th May 20177:00 amRNSFinal Results
24th Mar 201711:41 amRNSOutcome of the Board Meeting held on March 24 2017
7th Mar 20178:26 amRNSIntimation on Redemption of FCCBs
3rd Feb 201710:46 amRNSSubex Limited 3rd Quarter Results
7th Dec 20167:50 amRNSOutcome of Board Meeting held on December 06 2016
14th Sep 20167:47 amRNS1st Quarter Results
22nd Aug 201611:14 amRNSNotice of AGM
10th Aug 201610:43 amRNSOutcome of the Board Meeting- August 9, 2016
25th May 201610:51 amRNSSubex Limited-Outcome of Board Meeting
11th Feb 201612:18 pmRNS3rd Quarter Results
3rd Nov 20152:44 pmRNSResult of Meeting
27th Aug 20158:45 amRNSSubex Limited (The Company)-Update
13th Aug 20152:00 pmRNS1st Quarter Results
3rd Jul 201511:55 amRNSNotice of the Outcome of Bondholders meeting
27th May 201512:44 pmRNSNotice of AGM

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.